organization · Reporting owner
Sanitam Partners LLC
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Matinas BioPharma Holdings, Inc.
Report date June 10, 2026 · Filed August 13, 2026
Section 16 reporting ended · disclosed 2026-08-13. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Series C Convertible Preferred StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.59 | Direct | 0 |
Reported balance
After 2026-06-10 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-06-10 · Other · Disposed 1,406 · Balance 0 F1: On June 10, 2026, Sanitam Parnters LLC ("Sanitam") distributed its holdings in the Registrant's preferred stock and warrants to its members. As such Sanitam no longer beneficially owns any securities of the Registrant. F2: The Series C Convertible Preferred Stock of the Registrant is perpetual and has no expiration date. |
| Warrants to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.64 · Expires 2030-04-08 | Direct | 0 |
Reported balance
After 2026-06-10 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-06-10 · Other · Disposed 4,798,636 · Balance 0 F1: On June 10, 2026, Sanitam Parnters LLC ("Sanitam") distributed its holdings in the Registrant's preferred stock and warrants to its members. As such Sanitam no longer beneficially owns any securities of the Registrant. |
Filing footnotes · ownership attribution and instrument terms
F1: On June 10, 2026, Sanitam Parnters LLC ("Sanitam") distributed its holdings in the Registrant's preferred stock and warrants to its members. As such Sanitam no longer beneficially owns any securities of the Registrant.
F2: The Series C Convertible Preferred Stock of the Registrant is perpetual and has no expiration date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 10, 2026 Filed Aug 13, 2026 20:01 UTC | Matinas BioPharma Holdings, Inc. MTNB · Entity 8443 | OtherWarrants to Purchase Common Stock · Derivative | 4,798,636 | $0.64 Strike: $0.64 | $3,093,200.77 |
DisclosureSEC source: 0000921895-26-002105 · form413617016san_08132026.xml · derivative · entry 2 Sanitam Partners LLC · CIK 0002056830 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,798,636 shares Expires 2030-04-08 F1 · kind: On June 10, 2026, Sanitam Parnters LLC ("Sanitam") distributed its holdings in the Registrant's preferred stock and warrants to its members. As such Sanitam no longer beneficially owns any securities of the Registrant. Read SEC document |
| June 10, 2026 Filed Aug 13, 2026 20:01 UTC | Matinas BioPharma Holdings, Inc. MTNB · Entity 8443 | OtherSeries C Convertible Preferred Stock · Derivative | 1,406 | $0.59 Strike: $0.59 | $823.92 |
DisclosureSEC source: 0000921895-26-002105 · form413617016san_08132026.xml · derivative · entry 1 Sanitam Partners LLC · CIK 0002056830 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,399,318 shares Expires not disclosed F1 · kind: On June 10, 2026, Sanitam Parnters LLC ("Sanitam") distributed its holdings in the Registrant's preferred stock and warrants to its members. As such Sanitam no longer beneficially owns any securities of the Registrant. F2 · derivative.expiration_date: The Series C Convertible Preferred Stock of the Registrant is perpetual and has no expiration date. Read SEC document |
| April 08, 2025 Filed Apr 10, 2025 20:45 UTC Amendment | Matinas BioPharma Holdings, Inc. MTNB · Entity 8443 | PurchaseWarrants · Derivative | 2,399,318 | Not disclosed Strike: $0.64 | Not disclosed |
DisclosureSEC source: 0001477932-25-002594 · form4a.xml · derivative · entry 2 Sanitam Partners LLC · CIK 0002056830 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,798,636 Underlying: Common Stock · 2,399,318 shares Expires 2030-04-08 F1 · price: Pursuant to the Securities Purchase Agreement, dated February 13, 2025, Sanitam purchased an aggregate of 1,406 shares of the Issuer's Series C Convertible Preferred Stock, par value $0.0001 per share (the "Preferred Stock") with a stated value of $1,000 per share of Preferred Stock, and 4,798,636 Warrants for gross proceeds of $1,406,000.00. The Preferred Stock and Warrants were sold in two tranches with each tranche consisting of 703 shares of Preferred Stock and 2,399,318 Warrants. Read SEC document |
| April 08, 2025 Filed Apr 10, 2025 20:45 UTC Amendment | Matinas BioPharma Holdings, Inc. MTNB · Entity 8443 | PurchaseSeries C Convertible Preferred Stock · Derivative | 703 | $1,000.00 Strike: $0.59 | $703,000.00 |
DisclosureSEC source: 0001477932-25-002594 · form4a.xml · derivative · entry 1 Sanitam Partners LLC · CIK 0002056830 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,406 Underlying: Common Stock · 1,199,659 shares Expires not disclosed F1 · price: Pursuant to the Securities Purchase Agreement, dated February 13, 2025, Sanitam purchased an aggregate of 1,406 shares of the Issuer's Series C Convertible Preferred Stock, par value $0.0001 per share (the "Preferred Stock") with a stated value of $1,000 per share of Preferred Stock, and 4,798,636 Warrants for gross proceeds of $1,406,000.00. The Preferred Stock and Warrants were sold in two tranches with each tranche consisting of 703 shares of Preferred Stock and 2,399,318 Warrants. F3 · derivative.expiration_date: N/A F2 · balance_after: Each holder of Preferred Stock is entitled to vote on an as-converted to Common Stock basis with a per share voting price of $0.6393, granting Sanitam voting power from the Preferred Strock of up to 30.2% of the outstanding Common Stock. Sanitam's beneficial ownership is subject to a 9.99% limit on the shares of Common Stock issuable upon conversion of the Preferred Stock and a 4.99% limit on the shares of Common Stock issuable upon exercise of the Warrants. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.